Boston Scientific begins trial of Faraview PFA software
Boston Scientific (NYSE: BSX) began a new study of its Faraview software module for the Farawave pulsed field ablation (PFA) catheter.
Source: massdevice.com
Stay updated with breaking news from Afib Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Boston Scientific (NYSE: BSX) began a new study of its Faraview software module for the Farawave pulsed field ablation (PFA) catheter.
Boston Scientific announced that it initiated the AVANT GUARD clinical trial to evaluate its Farapulse pulsed-field ablation (PFA) system.